NATIONAL UNIV CORPORATION ASAHIKAWA MEDICAL UNIV has a total of 27 patent applications. It decreased the IP activity by 75.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV HOSPITALS CLEVELAND MEDICAL CT, UNIV LOMA LINDA and UNIV MASSACHUSETTS MEDICAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 10 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Singapore | 2 | |
#8 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Measurement | |
#5 | Computer technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Diagnosis and surgery | |
#5 | Object sterilising | |
#6 | Peptides | |
#7 | Fermentation | |
#8 | Analysing materials | |
#9 | Healthcare informatics | |
#10 | Measuring electric variables |
# | Name | Total Patents |
---|---|---|
#1 | Yoshida Akitoshi | 8 |
#2 | Nagaoka Taiji | 7 |
#3 | Hasebe Naoyuki | 7 |
#4 | Kawabe Junichi | 7 |
#5 | Kamada Kyosuke | 6 |
#6 | Kosaka Akemi | 6 |
#7 | Kobayashi Hiroya | 6 |
#8 | Ohkuri Takayuki | 6 |
#9 | Tamura Yukie | 3 |
#10 | Hayashi Hideaki | 3 |
Publication | Filing date | Title |
---|---|---|
CA3091099A1 | Cancer antigen peptide | |
WO2018079054A1 | Fat reducing agent for reducing amount of fat accumulated in hepatic cells, and blood cholesterol-reducing agent | |
EP3400952A1 | Derivatives of ferrichrom and their use as antitumoral agents | |
CA2994343A1 | Capillary vessel-derived stem cells, use of the same, and, method for producing the same | |
EP3306307A1 | Observation assisting device, information processing method, and program |